Benefit-risk of therapies for relapsing-remitting multiple sclerosis: testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat Harm (NNTH) and the likelihood to be helped or harmed (LHH): a systematic review and meta-analysis.

Mendes D, Alves C, Batel Marques F.

CNS Drugs. 2016 Oct;30(10):909-29. doi:10.1007/s40263-016-0377-9.

2016
http://link.springer.com/article/10.1007%2Fs40263-016-0377-9